Journal list Promote Sponsor
verified SJR 4,727 · Q1 • database Scopus / SJR & Web of Science indexed
Trends in Cancer
United States · Cell Press
workspace_premium Q1 — Oncology lock Subscription

Trends in Cancer

Trends in Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 101. It has an SJR impact factor of 4,727 and it has a best quartile of Q1. It has an SJR impact factor of 4,727.

ISSN: 2405-8033
Publisher: Cell Press
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
4,727 Q1
H-index 101
Acceptance rate pie_chart
28% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

4,727

H-index

101

Docs (year)

115

Docs 3y

329

Total refs

8630

Cites 3y

3694

Citable 3y

321

Cites/Doc 2y

11.32

Ref/Doc

75.04

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Emerging Roles for Eosinophils in the Tumor Microenvironment

View more

Zebrafish Xenografts for Drug Discovery and Personalized Medicine

View more

Firing Up Cold Tumors

View more

Filling the Gap on Caveolin-1 in Liver Carcinogenesis

View more

Fibroblasts Fuel Immune Escape in the Tumor Microenvironment

View more

Extraordinary Cancer Epigenomics: Thinking Outside the Classical Coding and Promoter Box

View more

Exosomes as a Multicomponent Biomarker Platform in Cancer

View more

Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics

View more

Epigenome Remodeling in Cholangiocarcinoma

View more

Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity

View more

Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells

View more

Epigenetic Biomarkers in Gallbladder Cancer

View more
SHOW MORE ARTICLES

Emerging Roles of GLI-Similar Kruppel-like Zinc Finger Transcription Factors in Leukemia and Other Cancers

View more

A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality

View more

Emerging Mechanisms by which EMT Programs Control Stemness

View more

DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer

View more

Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer

View more

Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors

View more

Cancer Is Not (Only) a Senescence Problem

View more

Cancer Genomics in Clinical Context

View more

Cancer and RASSF1A/RASSF1C, the Two Faces of Janus

View more

Breast Cancer: Multiple Subtypes within a Tumor?

View more

Brachyury: Strategies for Drugging an Intractable Cancer Therapeutic Target

View more

Agrin Mediates Angiogenesis in the Tumor Microenvironment

View more

FAQs